FDA social media guidance delayed again….until 2013!
March 29, 2011 5 Comments
I’m never surprised when government acts very slowly. But it has gotten beyond that now with the FDA’s pharmaceutical social media guidance. As Ogilvy’s Rohit Bhargava appropriately notes in the headline for this piece, the FDA just doesn’t appear to be that into providing guidance on social media.
Bhargava, citing an FDA document that outlines the agency’s priorities for 2011-2015, reports that a social media guidance, originally expected to be released by the end of last year, now likely won’t be released until at least 2013. Not for another two years. Even if the FDA actually releases a guidance that year (yeah, right), it will be almost four years after it held its public hearing on social media. It will also be almost 10 years after the debut of Facebook, seven years after the debut of Twitter, and even longer after message boards, blogs and ratings sites became available to the masses.
By then, the FDA will be way behind the times on this technology.
Pharmaceutical companies should probably give up waiting for FDA guidance at this point, if they haven’t already. It’s clear that they need to participate in social media. So they should just develop their social media plan and policies as best as they can using existing DDMAC guidelines. Use common sense and pay attention to when the FDA flags other pharmaceutical companies for violating DDMAC guidelines with social media, so you can learn from others’ mistakes.
It’s by no means an ideal way to go into social media. But the FDA clearly doesn’t care enough about this to publish a guidance anytime soon. Pharmaceutical companies still waiting can’t wait any longer. Just do the best you can with what you have.